VALERIYA GHETTE: Open Payments
NPI 1255928867 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 45 payments from 11 companies in 2025. Trend: 2023 $43 · 2024 $264 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $120 |
| Vanda Pharmaceuticals Inc. | 6 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Alkermes, Inc. | 2 | $33 |
| Bausch Health US, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Tris Pharma Inc | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, COBENFY, HETLIOZ, Qelbree, ARISTADA, APLENZIN, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
